Takeda, UCL deal

Takeda partnered with the University College London to identify and validate novel target genes to treat neurodegenerative disease. Under the three-year deal, the partners will focus on mechanistic approaches to identify genes or signaling pathways that modify neurodegenerative disease processes affecting neuronal health, including Huntington’s and Parkinson’s disease. ...